Abdominal obesity with metabolic syndrome MedDRA version: 6.1 Level: PT Classification code 10052066
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: One-hundred obese women (30Body Mass Index34.9 Kg/ m2) with abdominal body fat distribution (Waist to Hip ratio-WHR >0.85 e waist circumference > 88 cm) will be enrolled in the study. All women must have regular menses and must be aged between 25 and 45 years, in order to avoid bias on physical activity. Obese women must have one or more alterations of metabolic syndrome. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Basing on physical examination, individual clinical history and lab tests, women suffered of diabetes, thyroid diseases, Cushing's syndrome, hyperandrogenism or systemic diseases will be excluded. Tendency to bleeding, estrogen treatment or pregnancy will be considered exclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: This is a study of physiopatology that has to investigate the effect of physical activity, associated to low calorie diet regimen, on both the activity of the hypothalamic-pituitary-adrenal axis and inflammation and peripheral insulin sensibility.;Secondary Objective: The study will evaluate the eventual additive effect of aspirin treatment on the same parameters. These data will give informations about the relationship between the acute-phase proteins, cytokines, glucocorticoids and physical activity;Primary end point(s): Evaluation of physical activity effect alone or in combination with pharmacological treatment (aspirin) on flogosis and, then, on the activity of the HPA axis (urinary free cortisol excretion) | — |
Countries
Italy